The research team has found that pro nerve growth factor is produced by prostate cancer cells and will now perform the pre-clinical studies needed to test pro nerve growth factor as a new biomarker for the diagnosis, prognosis and therapeutic target of prostate cancer. 

Researchers 

Dr Severine Roselli, Professor Hubert Hondermarck

Research Area 
Project type 
Project Grant
Year of funding 
2014